Vyome Holdings/$HIND
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Vyome Holdings
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Ticker
$HIND
Sector
Primary listing
Employees
14
Headquarters
Website
Vyome Holdings Metrics
BasicAdvanced
$14m
-
-$4.75
-
-
Price and volume
Market cap
$14m
52-week high
$12.87
52-week low
$1.75
Average daily volume
24k
Financial strength
Current ratio
1.988
Quick ratio
1.858
Total debt to equity
0.831
Interest coverage (TTM)
-18.73%
Profitability
EBITDA (TTM)
-2.735
Gross margin (TTM)
68.43%
Net profit margin (TTM)
-3,209.75%
Operating margin (TTM)
-859.24%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-43.58%
Return on equity (TTM)
3,331.46%
Valuation
Price to revenue (TTM)
13.791
Price to book
4.94
Price to tangible book (TTM)
5.67
Price to free cash flow (TTM)
-1.176
Free cash flow yield (TTM)
-85.02%
Free cash flow per share (TTM)
-1.735
Growth
Revenue change (TTM)
24.43%
3-year revenue growth (CAGR)
-5.83%
Vyome Holdings News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Vyome Holdings stock?
Vyome Holdings (HIND) has a market cap of $14M as of April 30, 2026.
What is the P/E ratio for Vyome Holdings stock?
The price to earnings (P/E) ratio for Vyome Holdings (HIND) stock is 0 as of April 30, 2026.
Does Vyome Holdings stock pay dividends?
No, Vyome Holdings (HIND) stock does not pay dividends to its shareholders as of April 30, 2026.
When is the next Vyome Holdings dividend payment date?
Vyome Holdings (HIND) stock does not pay dividends to its shareholders.
What is the beta indicator for Vyome Holdings?
Vyome Holdings (HIND) does not currently have a Beta indicator.